Nouvelles Eulerpool Defence Therapeutics

Eulerpool-AFX Defence Therapeutics

Defence Therapeutics Actualités des actions

Defence Therapeutics est surveillé par de nombreux journalistes et investisseurs du monde entier. Nous regroupons ici les dernières actualités Defence Therapeutics.

• 14 mai ·

  Yahoo
  Defence Therapeutics Strengthens and Expands Global Patent Protection on Key Technologies
• 1 mai ·

  Yahoo
  Pancreatic Cancer: Successful Trial Against Pancreatic Cancer with Defence Therapeutics' ARM-002 Anti-Cancer Vaccine
• 23 avril ·

  Yahoo
  Defence's AccuTOX Anti-Cancer ARM-002 Vaccine Exhibits Potent Antigen Presentation
• 17 avril ·

  Yahoo
  Defence Therapeutics Signs with German Based FMS Consult GmbH for Financing Strategy to Support Defence Pipeline Growth
• 6 avril ·

  Yahoo
  Defence Therapeutics Announces Warrant Terms Amendment
• 26 mars ·

  Yahoo
  Defence's Successful Results on Its AccuTOX Anti-Cancer ARM Vaccine Creates a Potent Second-Generation Anti-Cancer ARM-002 Vaccine
• 22 mars ·

  Yahoo
  Defence Completes 2nd Tranche of Financing
• 4 mars ·

  Yahoo
  Defence Therapeutics Awarded Broad U.S. Patent Covering Its Pioneering Cancer-Killing AccuTOX(R) Technology
• 1 mars ·

  Yahoo
  Defence Announces Peer-Reviewed Publication on Accum-E7 Anti-Cancer Vaccine in Cancer Science Journal and Financing Update
• 31 janvier ·

  Yahoo
  Defence Therapeutics Completes 1st Tranche of Financing